Reaction
Idiopathic Pneumonia Syndrome reporting signals
As of the last recalculation, Idiopathic Pneumonia Syndrome appears in 294 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 404.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 46 | 404.1 | 406.0 |
| Busulfan | 64 | 367.8 | 369.3 |
| Fludarabine Phosphate | 104 | 289.2 | 290.0 |
| Melphalan Hydrochloride | 51 | 174.0 | 174.4 |
| Melphalan | 45 | 165.2 | 165.5 |
| Mesna Injection | 18 | 164.2 | 164.6 |
| Mesna | 18 | 161.2 | 161.5 |
| Micafungin Sodium | 15 | 131.9 | 132.2 |
| Anti-Thymocyte Globulin (Rabbit) | 14 | 129.0 | 129.2 |
| Ganciclovir | 15 | 109.3 | 109.4 |
| Ganciclovir Sodium | 15 | 105.7 | 105.8 |
| Alemtuzumab | 26 | 104.3 | 104.4 |
| Itraconazole | 16 | 102.5 | 102.7 |
| Voriconazole Injection | 22 | 77.4 | 77.5 |
| Mycophenolate Mofetil | 97 | 75.0 | 75.0 |
| Mycophenolate Mofetil Hydrochloride | 97 | 74.8 | 74.9 |
| Tacrolimus Ointment 0.1% | 86 | 68.7 | 68.7 |
| Tacrolimus Extended-Release Capsules | 86 | 68.5 | 68.6 |
| Tacrolimus | 96 | 63.9 | 64.0 |
| Voriconazole | 24 | 60.8 | 60.9 |
| Daspone | 8 | 59.7 | 59.8 |
| Dapsone Gel, 5% | 8 | 59.7 | 59.8 |
| Dapsone | 8 | 54.5 | 54.6 |
| Amphotericin B | 9 | 52.4 | 52.5 |
| Posaconazole | 9 | 40.4 | 40.4 |
| Posaconazole Delayed-Release | 6 | 39.5 | 39.5 |
| Ifosfamide | 9 | 30.6 | 30.6 |